News

Satya Nadella has unveiled BioEmu, Microsoft's new AI initiative aimed at accelerating drug discovery processes.
Gen Computing Quantum computing, poised to revolutionize industries from cryptography to drug discovery, leverages quantum ...
In this webinar, learn how scientists use advanced human brain models to uncover treatment strategies for complex ...
A major scientific advance in protein modeling developed by Microsoft Research AI for Science, has been published in Science.
Amarna Therapeutics and NorthX Biologics finalized an agreement to advance Nimvec AM510 gene therapy toward clinical trials for Type 1 Diabetes. Now in its fourth year, the MM+M Media Summit brings ...
A Financial District-based drug discovery company inked a $1 billion licensing agreement with pharmaceutical giant AbbVie to develop its signature cancer drug. IGI Therapeutics SA, a subsidiary of the ...
Hiding in Plain Sight Quantum computing has surged from theoretical curiosity to a transformative frontier, promising to ...
TandemAI, a company transforming drug discovery with state-of-the-art AI and physics-based technologies integrated with full wet lab capabilities, and Perpetual Medicines, which is advancing a ...
Researchers discovered how to flip the structure of complex drug compounds using a simple reagent, offering a game-changing ...
Revolution Medicines' proprietary data will train a bespoke version of NeuralPLexer, an AI model for protein-ligand ...
Revolution Medicines has zeroed in on Iambic Therapeutics’ AI drug discovery platform, striking a multi-year technology and research collaboration that gives Iambic the chance to earn up to $25 mil | ...
A fundamental discovery by University of Missouri scientists could help solve one of the most frustrating challenges in ...